HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1800733Generated: October 31, 2026
Sodium Bicarbonate → N-(5-{[5-({[3-(1-cyano-1-methylethyl)phenyl]carbonyl}amino)-2-methylphenyl]amino}[1,3]thiazolo[5,4-d]pyrimidin-2-yl)-1-methyl-1H-pyrazole-3-carboxamide
https://huagongshe.com/reaction/1800733
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Bicarbonate | HCID 516892 | — |
| Reactant | 1-methyl-1H-pyrazole-3-carboxylic acid | HCID 573176 | — |
| Reactant | Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1) | HCID 9886157 | — |
| Reactant | N-{3-[(2-amino[1,3]thiazolo[5,4-d]pyrimidin-5-yl)amino]-4-methylphenyl}-3-(1-cyano-1-methylethyl)benzamide | HCID 86646090 | — |
| Solvent | Pyridine | HCID 1049 | — |
| Product | N-(5-{[5-({[3-(1-cyano-1-methylethyl)phenyl]carbonyl}amino)-2-methylphenyl]amino}[1,3]thiazolo[5,4-d]pyrimidin-2-yl)-1-methyl-1H-pyrazole-3-carboxamide | HCID 59506930 | 40.3% |
Reaction Steps
To a solution of N-{3-[(2-amino[1,3]thiazolo[5,4-d]pyrimidin-5-yl)amino]-4-methylphenyl}-3-(1-cyano-1-methylethyl)benzamide (80 mg, 180 μmol) produced in Example D25(iii) in pyridine (3 mL) were added 1-methyl-1H-pyrazole-3-carboxylic acid (45 mg, 360 μmol) and O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (205 mg, 540 μmol), and the mixture was stirred at 90° C. for 17 hr. To the reaction mixture was added saturated aqueous sodium hydrogen carbonate solution (15 mL), and the mixture was extracted with ethyl acetate (20 mL, 5 mL). The combined organic layer was washed with saturated brine (5 mL), and dried over anhydrous sodium sulfate. The insoluble material was filtered off, and the filtrate was concentrated under reduced pressure. The obtained residue was purified by basic silica gel column chromatography (ethyl acetate/methanol=100/0→92/8), and the fractions containing the object product were concentrated under reduced pressure. The obtained residue was recrystallized from ethyl acetate to give the title compound (40 mg, 40%) as pale-yellow crystals.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08344135B2 |
|---|
| Source dataset | uspto-grants-2013_01 |
|---|
| ORD ID | ord-797545a9ebcb450ba1bf2b2e54696c24 |
|---|
| Source note | uspto-grants-2013_01 |
|---|